Sensorion News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.04.21	Sensorion Hosting Key Opinion Leader Webinar with Dr. Thomas Lenarz on the GJB2 Gene Related Hearing Loss on May 10, 2021 (Businesswire)
09.04.21	Sensorion Announces That a General Meeting of Shareholders Will Be Held Behind Closed Doors on May 18, 2021 Alongside the Publication of Its 2020 Annual Financial Report (Businesswire)
31.03.21	Sensorion Senior Management to Attend Four Conferences in April 2021 (Businesswire)
25.03.21	Sensorion Publishes Results of Extraordinary General Meeting Resolutions (Businesswire)
18.03.21	Sensorion Reports Full-Year 2020 Financial Results and Provides Business Highlights (Businesswire)
12.03.21	Sensorion to Present at Two Conferences on March 16th 2021 (Businesswire)
19.02.21	Sensorion Presents New Preclinical Data on SENS-401 at ARO 2021 (Businesswire)
17.02.21	Sensorion Announces That an Extraordinary General Meeting Will Be Held Behind Closed Doors on March 24, 2021 (Businesswire)
17.02.21	Sensorion : A Chardan Top Pick for 2021 (Businesswire)
15.02.21	Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important Pediatric and Adult Deafness Segments (Businesswire)
19.01.21	Sensorion Announces Preclinical Data Demonstrating SENS-401’s Potential to Preserve Residual Hearing After Cochlear Implantation (Businesswire)
07.01.21	Sensorion Announces Initiation of Coverage by Investment Banks Jefferies and Kempen With a "Buy” Recommendation (Businesswire)
05.01.21	Sensorion Provides an Update on Plans and Progress in the Development of SENS-401 for the Prevention of Hearing Loss (Businesswire)
15.12.20	Sonova Invests €5 Million in Sensorion as the Companies Plan a Collaboration in Hearing Loss (Businesswire)
20.11.20	Sensorion Hosting Key Opinion Leader Call with Dr. John Greinwald on Genetic Hearing Loss in Children on December 2, 2020 (Businesswire)
03.11.20	Sensorion Announces Attendance and a Presentation at Upcoming Conferences (Businesswire)
27.10.20	Sensorion and Novasep Announce Signature of a Gene Therapy Product Development and Manufacturing Agreement (Businesswire)
15.10.20	Sensorion Obtains €3 Million Loans, Including €2 Million Guaranteed by the French Government (PGE) and €1 Million as RDI Loan Through Bpifrance (Businesswire)
01.10.20	Sensorion Announces Attendance and Presentations at Upcoming Conferences (Businesswire)
18.09.20	Sensorion beschafft rund 31 Millionen Euro (36,5 Millionen US-Dollar) durch eine überzeichnete Privatplatzierung bei US-amerikanischen und europäischen Investoren (Businesswire)
18.09.20	Sensorion beginnt Kapitalerhöhung durch beschleunigtes Bookbuilding-Verfahren (Businesswire)
18.09.20	Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors (Businesswire)
17.09.20	Sensorion Launches a Capital Increase by Means of an Accelerated Bookbuild Offering (Businesswire)
14.08.20	Sensorion to present at the Oppenheimer Life Sciences Company Call Series and Virtual World Orphan Drug Congress USA (Businesswire)
29.07.20	Sensorion appoints five renowned experts to its Scientific Advisory Board (Businesswire)
20.07.20	Sensorion Will Present at the Bioprocessing Summit Europe Virtual Conference on July 21-23, 2020 (Businesswire)
16.07.20	Sensorion Hosting Key Opinion Leader Call with Dr. Michael Hoffer on Sudden Sensorineural Hearing Loss and SENS-401 as a Potential Treatment Option on July 23, 2020 (Businesswire)
06.07.20	Sensorion Appoints Dr Edwin Moses, Former Ablynx CEO, as Chairman of the Board (Businesswire)
17.06.20	Sensorion Announces Initiation of Coverage by US Investment Bank Chardan with a "Buy” Recommendation (Businesswire)
09.06.20	Sensorion Announces Positive Preliminary Preclinical Data From Its Otoferlin Gene Therapy Program (Businesswire)
21.05.20	Sensorion Publishes Results of General Assembly Resolutions (Businesswire)
29.04.20	Sensorion Announces It Will Hold Its General Assembly on May 20, 2020 Behind Closed Doors Alongside the Publication of Its 2019 Annual Financial Report (Businesswire)
24.04.20	Sensorion reschedules General Assembly to May 20 (Businesswire)
02.04.20	Sensorion Reports Full-year 2019 Financial Results and Business Update (Businesswire)
13.03.20	Sensorion provides update on SENS-401 SSNHL Phase 2 AUDIBLE-S trial enrollment (Businesswire)
19.02.20	Sensorion appoints gene therapy expert Dr Géraldine Honnet as Chief Medical Officer (Businesswire)
13.02.20	Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into Ordinary Shares (Businesswire)
10.02.20	Sensorion Announces the Full Conversion of Invus Convertible Bonds Into Ordinary Shares (Businesswire)
03.02.20	Sensorion to Attend and Present at LSX World Congress 2020 (Businesswire)
30.01.20	Sensorion Presents New SENS-401 Preclinical Data at ARO Midwinter Meeting 2020 (Businesswire)
10.01.20	Sensorion Announces its Presence in San Francisco during the 38th annual J.P. Morgan Healthcare Conference (Businesswire)
23.12.19	Sensorion Announces Positive Data Safety Monitoring Board Review of Phase 2 Trial for SENS-401 in Sudden Sensorineural Hearing Loss (Businesswire)
23.12.19	Sensorion Announces €5.6m Non-Dilutive Funding to Support SENS-401 Phase 2 Study in Sudden Sensorineural Hearing Loss; French Ministry of Armed Forces to Participate in the Study (Businesswire)
02.12.19	Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy (Businesswire)
07.11.19	Sensorion Announces an Oral Presentation of New SENS-401 Preclinical Data at ISIET 2019 in Hannover (Businesswire)
31.10.19	Sensorion reports its 2019 first half results (Businesswire)
23.10.19	Sensorion Announces a Poster Presentation of New SENS-401 Preclinical Data at SFN 2019 in Chicago (Businesswire)
17.10.19	Sensorion Announces the Last Patient’s Last Visit in SENS-111 Phase 2 Clinical Trial (Businesswire)
17.09.19	Sensorion Announces Two Presentations at AAO-HNSF 2019 in New Orleans (Businesswire)
11.09.19	Sensorion Announces Three Presentations at IEB 2019 in Padua (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	82.24	2.93 %	K V
Part Grp Hldg	1’404.00	1.67 %	K V
CieFinRichemont	170.10	1.10 %	K V
Kuehne+Nagel Int	206.60	0.98 %	K V
Holcim	89.82	0.92 %	K V
ABB	53.58	0.04 %	K V
Givaudan	3’941.00	-0.10 %	K V
Geberit	498.50	-0.46 %	K V
Alcon	80.46	-0.54 %	K V
Sonova Hldg	314.80	-1.16 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Sensorion SA

Aktien Top/Flop

Meistgelesene Nachrichten